Which statement best describes monitoring for carbimazole therapy?

• A. Blood tests are performed every 4-6 weeks during dose changes
• B. Blood tests every 6 months are sufficient
• C. No monitoring is required
• D. Urinalysis alone is sufficient

Answer: (A)

Monitoring for carbimazole hinges on tracking thyroid function as the dose is adjusted. When you change the dose, it takes a few weeks for thyroid hormone levels to respond to the new amount of drug, so checking thyroid function tests every 4–6 weeks ensures you can see the actual effect of the change and fine-tune the dose to achieve normal thyroid levels. This interval strikes a balance between capturing the drug’s effect and avoiding over- or under-treatment. If you waited much longer (for example, every 6 months), you’d risk missing instability during dose changes. Urinalysis does not reflect thyroid status, and having no monitoring would miss potential abnormalities. Once thyroid function is stable, testing can be spaced out, but during dose changes the 4–6 week window is the appropriate approach. It’s also important to counsel patients to report symptoms such as fever or sore throat, since rare adverse effects like neutropenia can occur with thionamides.